Light-Driven Organocatalytic Birch Reduction for Late-Stage Drug Modification and sp³-Rich Spirocycle Synthesis

Area of Science:

• Organic Chemistry
• Photocatalysis
• Medicinal Chemistry

Background:

• The Birch reduction is crucial but limited by harsh conditions and poor functional group tolerance.
• Existing photochemical methods are often restricted to specific substrates and unsuitable for complex pharmaceuticals.

Purpose of the Study:

• To develop a practical, mild, and broadly applicable organocatalytic system for Birch-type reductions.
• To enable the synthesis of complex drug molecules and valuable spirocyclic scaffolds.

Main Methods:

• Utilized an indoline-2-thione anion catalyst with light irradiation.
• Developed a protocol for Birch-type reductions of electron-rich benzenes and heteroarenes.
• Demonstrated late-stage functionalization of drug molecules and a telescoped reduction/spirocyclization sequence.

Main Results:

• Achieved mild Birch-type reductions of electron-rich arenes and heteroarenes (Ered < -3.4 V vs SCE).
• Showcased broad substrate scope, including sensitive functional groups in drug molecules.
• Streamlined access to sp3-rich spirocyclic scaffolds via a two-step sequence.
• Demonstrated scalability in batch and continuous-flow operations.

Conclusions:

• The developed organocatalytic system offers a practical and mild alternative for Birch-type reductions.
• This light-driven approach facilitates the synthesis of complex, drug-like molecules and valuable scaffolds.
• The method holds significant translational potential for industrial applications in medicinal chemistry.